PPBT
Purple Biotech
PPBT
PPBT
17 hedge funds and large institutions have $388K invested in Purple Biotech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 16 → 17 (+1)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
Holders
17
Holding in Top 10
–
Calls
$76K
Puts
$5K
Top Buyers
| 1 | +$43.1K | |
| 2 | +$9.15K | |
| 3 | +$7.55K | |
| 4 |
WAOI
Wealth Advisors of Iowa
West Des Moines,
Iowa
|
+$1.09K |
| 5 |
VVP
Venture Visionary Partners
Sylvania,
Ohio
|
+$921 |
Top Sellers
| 1 | -$13.8K | |
| 2 | -$8.17K | |
| 3 | -$4.65K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$3.57K |
| 5 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
-$1.9K |